Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
China
Dazhu Center for Disease Prevention and Control, Dazhou, Sichuan Cuiping Center for Disease Prevention and Control, Yibin, Sichuan Xingwen Center for Disease Prevention and Control, Yibin, Sichuan Age range
2 Months – 6 Years
Last updated January 2024